Body · lesson 3 of 11
Cardiovascular lipids — beyond the basic cholesterol panel
LDL/HDL/triglycerides vs the more informative particle markers, ApoB and Lp(a).
6 min read · reviewed October 2026
A standard lipid panel gives you four numbers: total cholesterol, LDL, HDL, and triglycerides. It's cheap, routine, and genuinely useful — but it has a real blind spot. Cholesterol values estimate how much cholesterol is being carried, not how many particles are doing the carrying. And it's the particles that actually lodge in artery walls.
The standard panel vs the advanced particle markers
The sum of cholesterol across all particle types. A blunt headline number — on its own it can be misleading, because high HDL inflates it and the breakdown matters more than the total.
Cholesterol carried in low-density (atherogenic) particles — the 'lowering this lowers risk' marker most guidelines target. Usually estimated by calculation rather than measured directly, which adds some imprecision.
Cholesterol in high-density particles, broadly associated with lower risk — but it's a marker, not a lever you should try to force upward. Very high HDL is not automatically protective.
Circulating fat. High triglycerides often track with insulin resistance and a poor metabolic state — which is why this marker pulls double duty (see the trig/HDL ratio).
Counts the actual NUMBER of atherogenic particles (each carries one ApoB protein). Many lipid specialists consider it the single most informative cardiovascular-risk marker, because particle count can be high even when LDL cholesterol looks acceptable.
A largely GENETIC, independent risk particle most people never get tested. It's mostly fixed by your genes, so a once-in-a-lifetime test tells you whether you carry elevated inherited risk — valuable information that changes how aggressively the other markers should be managed.
Why particle count (ApoB) can beat cholesterol concentration
Two people can have the same LDL cholesterol but a very different number of particles carrying it. Risk tracks more with how MANY particles you have than with how much cholesterol is inside them — and ApoB counts the particles.
How it works →
Atherosclerosis is driven by atherogenic lipoproteins (LDL, VLDL remnants, Lp(a)) crossing into the artery wall and getting retained. Each such particle carries exactly one apolipoprotein B (ApoB) molecule, so ApoB is essentially a direct particle count. When particles are small and cholesterol-depleted — common in insulin resistance — you can have many particles (high ApoB, high risk) while the calculated LDL cholesterol looks reassuringly normal. This is the 'discordance' that a cholesterol-only panel can miss.
What the studies show →
Large bodies of observational and Mendelian-randomization evidence support ApoB as a strong, often superior predictor of cardiovascular risk compared with LDL cholesterol, and Lp(a) is well-established as an independent, largely genetic risk factor. Specific guideline targets and the degree to which ApoB should replace LDL are still actively debated, and cutoffs differ by organization — so think of ApoB/Lp(a) as 'more information,' interpreted with a clinician, rather than a settled single threshold.
Test Lp(a) once; track ApoB over time
Because Lp(a) is mostly genetic and stable, a single lifetime measurement usually answers the question. ApoB, by contrast, responds to diet, medication, and lifestyle — so it's a marker worth trending, much like LDL.
Why might ApoB give a clearer picture of cardiovascular risk than LDL cholesterol alone?
- It measures inflammation directly
- It counts the number of artery-damaging particles, which can be high even when LDL cholesterol looks normal
- It is unaffected by diet, so it never changes
- It replaces the need for any other lipid test
Show the answer →
B.It counts the number of artery-damaging particles, which can be high even when LDL cholesterol looks normal
Each atherogenic particle carries one ApoB protein, so ApoB is effectively a particle count. Risk tracks with particle number, and that count can be elevated even when the calculated LDL cholesterol reads normal — a 'discordance' the standard panel can miss. It complements, rather than replaces, the rest of the panel.
Log LDL, HDL, triglycerides — and ApoB / Lp(a) if you have them — so changes from diet, exercise, or treatment show up as a real trend.